PUBLIC COMPANY
saveCStone Pharmaceuticals Co Ltd
updated 2mo ago
community read0 votes
pipeline
3
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
2Phase 21Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
- phase2A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer
- —Safety and Efficacy of Avapritinib in Chinese Patients With Gastrointestinal Stromal Tumor (GIST) in the Real World
- phase3Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma
- phase3A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma
- phase1A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas
- phase3A Study of CS1001 in Subjects With Stage IV Non-Small Cell Lung Cancer
- phase1A Study of CS1001 in Subjects with Advanced Solid Tumors
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that